NM_003998.4:c.2592+58T>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003998.4(NFKB1):​c.2592+58T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.199 in 1,468,294 control chromosomes in the GnomAD database, including 31,307 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3979 hom., cov: 32)
Exomes 𝑓: 0.20 ( 27328 hom. )

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.582

Publications

45 publications found
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]
NFKB1 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 12
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • common variable immunodeficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 4-102612664-T-A is Benign according to our data. Variant chr4-102612664-T-A is described in ClinVar as Benign. ClinVar VariationId is 1256826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.299 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NFKB1NM_003998.4 linkc.2592+58T>A intron_variant Intron 22 of 23 ENST00000226574.9 NP_003989.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NFKB1ENST00000226574.9 linkc.2592+58T>A intron_variant Intron 22 of 23 1 NM_003998.4 ENSP00000226574.4
NFKB1ENST00000505458.5 linkc.2589+58T>A intron_variant Intron 22 of 23 1 ENSP00000424790.1

Frequencies

GnomAD3 genomes
AF:
0.217
AC:
32923
AN:
151980
Hom.:
3980
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.304
Gnomad AMI
AF:
0.253
Gnomad AMR
AF:
0.158
Gnomad ASJ
AF:
0.222
Gnomad EAS
AF:
0.0603
Gnomad SAS
AF:
0.205
Gnomad FIN
AF:
0.115
Gnomad MID
AF:
0.323
Gnomad NFE
AF:
0.204
Gnomad OTH
AF:
0.235
GnomAD4 exome
AF:
0.197
AC:
259852
AN:
1316196
Hom.:
27328
AF XY:
0.199
AC XY:
130971
AN XY:
658598
show subpopulations
African (AFR)
AF:
0.310
AC:
9348
AN:
30138
American (AMR)
AF:
0.110
AC:
4647
AN:
42342
Ashkenazi Jewish (ASJ)
AF:
0.207
AC:
4997
AN:
24122
East Asian (EAS)
AF:
0.0689
AC:
2670
AN:
38736
South Asian (SAS)
AF:
0.221
AC:
17812
AN:
80598
European-Finnish (FIN)
AF:
0.132
AC:
6500
AN:
49328
Middle Eastern (MID)
AF:
0.254
AC:
1009
AN:
3976
European-Non Finnish (NFE)
AF:
0.204
AC:
201829
AN:
991752
Other (OTH)
AF:
0.200
AC:
11040
AN:
55204
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
9867
19733
29600
39466
49333
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6778
13556
20334
27112
33890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.216
AC:
32923
AN:
152098
Hom.:
3979
Cov.:
32
AF XY:
0.211
AC XY:
15711
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.303
AC:
12567
AN:
41454
American (AMR)
AF:
0.158
AC:
2410
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.222
AC:
771
AN:
3472
East Asian (EAS)
AF:
0.0604
AC:
313
AN:
5180
South Asian (SAS)
AF:
0.205
AC:
989
AN:
4820
European-Finnish (FIN)
AF:
0.115
AC:
1212
AN:
10578
Middle Eastern (MID)
AF:
0.316
AC:
93
AN:
294
European-Non Finnish (NFE)
AF:
0.204
AC:
13848
AN:
67980
Other (OTH)
AF:
0.232
AC:
489
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1303
2606
3908
5211
6514
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
336
672
1008
1344
1680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.210
Hom.:
427
Bravo
AF:
0.220
Asia WGS
AF:
0.132
AC:
458
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 19, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 12, 2023
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 21% of patients studied by a panel of primary immunodeficiencies. Number of patients: 20. Only high quality variants are reported. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.8
DANN
Benign
0.65
PhyloP100
-0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4648110; hg19: chr4-103533821; COSMIC: COSV56961257; API